Investigational PPAR-delta Agonist for PBC Treatment and Race-Based Considerations for PBC Diagnosis: Conference Coverage of AASLD

Listen as Stuart C. Gordon, MD, FAASLD, discusses exciting new PBC data from AASLD 2023, including a late-breaking study of a PPAR-delta agonist and a study that explored racial differences as they relate to the presentation and diagnosis of PBC.